Ismail Sherazaan D, Sebaa Shorok, Abrahams Bianca, Nason Martha C, Mumby Mitchell J, Dikeakos Jimmy D, Joseph Sarah B, Moeser Matthew, Swanstrom Ronald, Garrett Nigel, Williamson Carolyn, Quinn Thomas C, Abrahams Melissa-Rose, Redd Andrew D
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
J Virol. 2025 Jun 24:e0021725. doi: 10.1128/jvi.00217-25.
HIV-1 Nef mediates immune evasion and viral pathogenesis in part through the downregulation of cell surface cluster of differentiation 4 (CD4) and major histocompatibility complex class I (MHC-I) on infected cells. While the Nef function of circulating viral populations found early in infection has been associated with reservoir size in early-treated cohorts, there is limited research on how its activity impacts reservoir size in people initiating treatment during chronic infection. In addition, there is little research on its role in the persistence of viral variants during long-term antiretroviral therapy (ART). Phylogenetically distinct genes ( = 82) with varying estimated times of reservoir entry were selected from viral outgrowth variants stimulated from the reservoir of South African women living with HIV who initiated ART during chronic infection ( = 16). These genes were synthesized and used in a pseudovirus infection assay that measures CD4 and MHC-I downregulation via flow cytometry. Downregulation measures were compared to the size of the replication-competent viral reservoir (RC-VR), estimated by quantitative viral outgrowth assay at 5 years after treatment initiation, as well as proviral survival time. Maximum Nef-mediated MHC-I downregulation was significantly associated with RC-VR size ( = 0.034), but this association was not observed for CD4 downregulation. Conversely, we did not find a consistent association between intraparticipant MHC-I or CD4 downregulation and the variant timing of entry into the reservoir. These data support a role for Nef-mediated MHC-I downregulation in determining RC-VR size, but more work is needed to determine Nef's role in the survival of individual viral variants over time.IMPORTANCERational design of HIV cure interventions requires an understanding of the viral determinants of reservoir dynamics. For an equitable cure, it needs to be broadly applicable. While African women bear the greatest burden of HIV globally, most cure research has focused on men in the global North. Our study aims to elucidate viral determinants of HIV persistence in South African women on antiretroviral therapy. We hypothesized that the HIV protein Nef subverts immune clearance of infected cells by downregulating surface levels of two cellular proteins, CD4 and MHC-I. We compared this downregulation capacity with reservoir size and variant survival in the reservoir. We found a positive association between an individual's reservoir size and MHC-I downregulation, but there was little evidence for a survival benefit with stronger MHC-I reduction. These data support earlier work and suggest that Nef's interaction with MHC-I may be a target to restrict the latent reservoir in cure strategies.
HIV-1 Nef部分通过下调受感染细胞表面的分化簇4(CD4)和主要组织相容性复合体I类(MHC-I)来介导免疫逃逸和病毒发病机制。虽然在感染早期发现的循环病毒群体的Nef功能与早期治疗队列中的病毒储存库大小有关,但关于其活性如何影响慢性感染期间开始治疗的人群的病毒储存库大小的研究有限。此外,关于其在长期抗逆转录病毒疗法(ART)期间病毒变体持续存在中的作用的研究也很少。从慢性感染期间开始接受ART的南非HIV感染者的病毒储存库中刺激产生的病毒生长变体中,选择了82个系统发育上不同的基因,这些基因的储存库进入估计时间各不相同(n = 16)。合成了这些基因,并用于通过流式细胞术测量CD4和MHC-I下调的假病毒感染试验。将下调测量结果与治疗开始后5年通过定量病毒生长试验估计的有复制能力的病毒储存库(RC-VR)大小以及前病毒存活时间进行比较。Nef介导的最大MHC-I下调与RC-VR大小显著相关(P = 0.034),但CD4下调未观察到这种关联。相反,我们没有发现参与者体内MHC-I或CD4下调与病毒变体进入储存库的时间之间存在一致的关联。这些数据支持Nef介导的MHC-I下调在确定RC-VR大小中的作用,但需要更多工作来确定Nef在单个病毒变体随时间存活中的作用。
重要性
HIV治愈干预措施的合理设计需要了解病毒储存库动态的病毒决定因素。为了实现公平的治愈,它需要具有广泛的适用性。虽然非洲女性在全球范围内承受着最大的HIV负担,但大多数治愈研究都集中在全球北方的男性身上。我们的研究旨在阐明接受抗逆转录病毒治疗的南非女性中HIV持续存在的病毒决定因素。我们假设HIV蛋白Nef通过下调两种细胞蛋白CD4和MHC-I的表面水平来破坏受感染细胞的免疫清除。我们将这种下调能力与病毒储存库大小和储存库中的变体存活情况进行了比较。我们发现个体的病毒储存库大小与MHC-I下调之间存在正相关,但几乎没有证据表明更强的MHC-I降低会带来存活益处。这些数据支持了早期的研究工作,并表明Nef与MHC-I的相互作用可能是在治愈策略中限制潜伏病毒储存库的一个靶点。